Pharmaceutical Law Insight
US court wants clarification on pay-to-delay settlements
The US Court of Appeals has called on the District Court to revisit a 2005 decision which set the legal precedent to allow so-called ‘pay-to-delay’ deals within the pharmaceutical industry.The rest of this document is only available to i-law.com online subscribers.
If you are already a subscriber, please enter your details below to log in.
